News

The FDA’s Friday announcement follows an announcement made March 10 by HHS that the agency is revisiting the GRAS final rule ...
The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.
The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...
The Food and Drug Administration is planning to expand its review of food additives beyond artificial dyes, targeting ...
The U.S. Food and Drug Administration plans to step up safety reviews on chemicals in foods, including one widely used as a ...
Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...
FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes ...
Brigham Buhler, a MAHA influencer and biotech entrepreneur, has Robert F. Kennedy’s ear. But will RFK listen to his call to ...
As Stat reports, the federal judge's ruling means patients will lose access to less-expensive versions of Eli Lilly's weight loss drug, as well as diabetes treatment Mounjaro, from compounding ...
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...